• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    189.53 Up 0.57(0.30%) Dec 19, 4:00PM EST
    |After Hours : 189.53 Down 0.00 (0.00%) Dec 19, 6:51PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.8
    Mean Recommendation (last week):1.8
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:209.90
    Median Target:214.50
    High Target:240.00
    Low Target:170.00
    No. of Brokers:20

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Mar 26, 2012Canaccord GenuityInitiated Buy
    Feb 23, 2012UBSUpgradeNeutralBuy
    Feb 10, 2012Robert W. BairdUpgradeNeutralOutperform
    Dec 9, 2011Barclays CapitalInitiated Overweight
    Apr 25, 2011NeedhamDowngradeBuyHold
    Nov 12, 2010Robert W. BairdInitiated Neutral
    Oct 22, 2010JefferiesDowngradeBuyHold
    Jun 3, 2010OppenheimerUpgradePerformOutperform
    Jan 20, 2010OppenheimerInitiated Perform
    Jul 17, 2009ThinkEquityInitiated Sell

    More Upgrades & Downgrades for ALXN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0998
    Buy0888
    Hold0566
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.